Exelixis Book Value Per Share from 2010 to 2024

EXEL Stock

USD 35.93 0.52 1.43%

Exelixis Book Value Per Share yearly trend continues to be quite stable with very little volatility. Book Value Per Share may rise above 7.37 this year. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Exelixis according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

7.02041069

Current Value

7.37

Quarterly Volatility

3.64175785

Credit Downgrade

Yuan Drop

Covid

Check Exelixis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Exelixis' main balance sheet or income statement drivers, such as Interest Expense of 64.9 M, Total Revenue of 1.9 B or Gross Profit of 1.8 B, as well as many indicators such as Price To Sales Ratio of 3.81, Dividend Yield of 0.0 or PTB Ratio of 4.24. Exelixis financial statements analysis is a perfect complement when working with Exelixis Valuation or Volatility modules.

Check out the analysis of Exelixis Correlation against competitors.

For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.

Latest Exelixis' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Exelixis over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Exelixis' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Exelixis' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 7.96 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Exelixis Book Value Per Share Regression Statistics

	Arithmetic Mean	3.72
	Coefficient Of Variation	97.99
	Mean Deviation	3.41
	Median	6.10
	Standard Deviation	3.64
	Sample Variance	13.26
	Range	8.8991
	R-Value	0.90
	Mean Square Error	2.70
	R-Squared	0.81
	Slope	0.73
	Total Sum of Squares	185.67

Exelixis Book Value Per Share History

	2024	7.37
	2022	7.12
	2021	7.02
	2016	6.1
	2014	-0.59
	2013	0.36

Other Fundumenentals of Exelixis

Tangible Book Value Per Share

Exelixis Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Net Debt	Accounts Payable	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Long Term Debt	Good Will	Intangible Assets	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.72	-0.68	0.95	0.94	0.96	0.34	0.96	-0.34	-0.33	-0.55	-0.26	-0.43	0.94	-0.09	0.99	-0.69	0.83	0.78	0.93	-0.59	0.97	0.91	0.78
Total Stockholder Equity	0.99		0.78	-0.76	0.92	0.95	0.97	0.2	0.97	-0.39	-0.26	-0.61	-0.25	-0.39	0.94	-0.03	0.99	-0.73	0.81	0.79	0.9	-0.64	0.99	0.94	0.75
Retained Earnings	0.72	0.78		-0.61	0.67	0.69	0.69	-0.18	0.68	-0.6	0.34	-0.58	-0.53	-0.48	0.78	-0.05	0.78	-0.53	0.39	0.44	0.73	-0.61	0.78	0.75	0.59
Net Debt	-0.68	-0.76	-0.61		-0.55	-0.82	-0.76	0.15	-0.82	0.4	0.07	0.77	-0.04	-0.01	-0.74	-0.1	-0.67	0.82	-0.67	-0.77	-0.46	0.64	-0.76	-0.83	-0.46
Accounts Payable	0.95	0.92	0.67	-0.55		0.89	0.89	0.43	0.88	-0.26	-0.25	-0.49	-0.39	-0.54	0.92	-0.3	0.94	-0.61	0.79	0.72	0.91	-0.51	0.9	0.84	0.8
Net Receivables	0.94	0.95	0.69	-0.82	0.89		0.91	0.21	0.95	-0.32	-0.28	-0.66	-0.25	-0.39	0.97	-0.12	0.94	-0.78	0.83	0.84	0.79	-0.62	0.93	0.92	0.72
Short Term Investments	0.96	0.97	0.69	-0.76	0.89	0.91		0.24	0.98	-0.39	-0.33	-0.6	-0.14	-0.29	0.88	-0.06	0.94	-0.74	0.82	0.8	0.83	-0.62	0.95	0.95	0.72
Total Liab	0.34	0.2	-0.18	0.15	0.43	0.21	0.24		0.25	0.22	-0.57	0.2	0.16	-0.02	0.24	-0.33	0.23	0.03	0.47	0.15	0.36	0.12	0.22	0.12	0.15
Total Current Assets	0.96	0.97	0.68	-0.82	0.88	0.95	0.98	0.25		-0.35	-0.34	-0.59	-0.09	-0.24	0.92	-0.09	0.92	-0.73	0.84	0.8	0.8	-0.6	0.96	0.97	0.72
Short Term Debt	-0.34	-0.39	-0.6	0.4	-0.26	-0.32	-0.39	0.22	-0.35		-0.16	0.43	0.16	0.12	-0.35	-0.07	-0.38	0.4	-0.06	-0.23	-0.33	0.88	-0.36	-0.35	-0.21
Common Stock	-0.33	-0.26	0.34	0.07	-0.25	-0.28	-0.33	-0.57	-0.34	-0.16		-0.19	-0.54	-0.23	-0.13	-0.08	-0.22	0.11	-0.44	-0.29	-0.21	0.05	-0.23	-0.22	-0.15
Long Term Debt	-0.55	-0.61	-0.58	0.77	-0.49	-0.66	-0.6	0.2	-0.59	0.43	-0.19		0.32	0.29	-0.59	-0.14	-0.6	0.95	-0.55	-0.84	-0.44	0.66	-0.59	-0.56	-0.38
Good Will	-0.26	-0.25	-0.53	-0.04	-0.39	-0.25	-0.14	0.16	-0.09	0.16	-0.54	0.32		0.94	-0.39	0.22	-0.38	0.17	0.03	-0.16	-0.41	0.17	-0.19	-0.11	-0.47
Intangible Assets	-0.43	-0.39	-0.48	-0.01	-0.54	-0.39	-0.29	-0.02	-0.24	0.12	-0.23	0.29	0.94		-0.5	0.23	-0.52	0.24	-0.13	-0.3	-0.55	0.22	-0.31	-0.22	-0.62
Property Plant Equipment	0.94	0.94	0.78	-0.74	0.92	0.97	0.88	0.24	0.92	-0.35	-0.13	-0.59	-0.39	-0.5		-0.19	0.94	-0.68	0.76	0.73	0.84	-0.59	0.93	0.91	0.77
Current Deferred Revenue	-0.09	-0.03	-0.05	-0.1	-0.3	-0.12	-0.06	-0.33	-0.09	-0.07	-0.08	-0.14	0.22	0.23	-0.19		-0.06	-0.16	-0.04	0.1	0.02	-0.06	-0.04	-0.11	-0.21
Net Tangible Assets	0.99	0.99	0.78	-0.67	0.94	0.94	0.94	0.23	0.92	-0.38	-0.22	-0.6	-0.38	-0.52	0.94	-0.06		-0.71	0.8	0.78	0.93	-0.62	0.96	0.89	0.76
Long Term Debt Total	-0.69	-0.73	-0.53	0.82	-0.61	-0.78	-0.74	0.03	-0.73	0.4	0.11	0.95	0.17	0.24	-0.68	-0.16	-0.71		-0.71	-0.94	-0.54	0.7	-0.7	-0.67	-0.46
Capital Surpluse	0.83	0.81	0.39	-0.67	0.79	0.83	0.82	0.47	0.84	-0.06	-0.44	-0.55	0.03	-0.13	0.76	-0.04	0.8	-0.71		0.85	0.69	-0.42	0.83	0.75	0.42
Deferred Long Term Liab	0.78	0.79	0.44	-0.77	0.72	0.84	0.8	0.15	0.8	-0.23	-0.29	-0.84	-0.16	-0.3	0.73	0.1	0.78	-0.94	0.85		0.63	-0.59	0.75	0.7	0.53
Long Term Investments	0.93	0.9	0.73	-0.46	0.91	0.79	0.83	0.36	0.8	-0.33	-0.21	-0.44	-0.41	-0.55	0.84	0.02	0.93	-0.54	0.69	0.63		-0.51	0.88	0.76	0.75
Short Long Term Debt	-0.59	-0.64	-0.61	0.64	-0.51	-0.62	-0.62	0.12	-0.6	0.88	0.05	0.66	0.17	0.22	-0.59	-0.06	-0.62	0.7	-0.42	-0.59	-0.51		-0.59	-0.57	-0.39
Net Invested Capital	0.97	0.99	0.78	-0.76	0.9	0.93	0.95	0.22	0.96	-0.36	-0.23	-0.59	-0.19	-0.31	0.93	-0.04	0.96	-0.7	0.83	0.75	0.88	-0.59		0.95	0.69
Net Working Capital	0.91	0.94	0.75	-0.83	0.84	0.92	0.95	0.12	0.97	-0.35	-0.22	-0.56	-0.11	-0.22	0.91	-0.11	0.89	-0.67	0.75	0.7	0.76	-0.57	0.95		0.74
Capital Stock	0.78	0.75	0.59	-0.46	0.8	0.72	0.72	0.15	0.72	-0.21	-0.15	-0.38	-0.47	-0.62	0.77	-0.21	0.76	-0.46	0.42	0.53	0.75	-0.39	0.69	0.74

Click cells to compare fundamentals

About Exelixis Financial Statements

Exelixis investors utilize fundamental indicators, such as Book Value Per Share, to predict how Exelixis Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Book Value Per Share	7.02	7.37
Tangible Book Value Per Share	6.82	7.16

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Exelixis is a strong investment it is important to analyze Exelixis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Exelixis' future performance. For an informed investment choice regarding Exelixis Stock, refer to the following important reports:

How To Invest In Exelixis

Details

Is Exelixis Stock a good investment?

Details

What is Exelixis' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Exelixis Correlation against competitors.

For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.

You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

121.699

Earnings Share

1.55

Revenue Per Share

7.032

Quarterly Revenue Growth

0.143

Return On Assets

0.1281

The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Exelixis Book Value Per Share from 2010 to 2024

Latest Exelixis' Book Value Per Share Growth Pattern

Exelixis Book Value Per Share Regression Statistics

Exelixis Book Value Per Share History

Other Fundumenentals of Exelixis

Exelixis Book Value Per Share component correlations

About Exelixis Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY